Transplant benefit for patients with hepatocellular carcinoma
about
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients.
P2860
Transplant benefit for patients with hepatocellular carcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Transplant benefit for patients with hepatocellular carcinoma
@ast
Transplant benefit for patients with hepatocellular carcinoma
@en
Transplant benefit for patients with hepatocellular carcinoma
@nl
type
label
Transplant benefit for patients with hepatocellular carcinoma
@ast
Transplant benefit for patients with hepatocellular carcinoma
@en
Transplant benefit for patients with hepatocellular carcinoma
@nl
prefLabel
Transplant benefit for patients with hepatocellular carcinoma
@ast
Transplant benefit for patients with hepatocellular carcinoma
@en
Transplant benefit for patients with hepatocellular carcinoma
@nl
P2860
P356
P1476
Transplant benefit for patients with hepatocellular carcinoma
@en
P2093
Alessandro Vitale
Michael Volk
P2860
P304
P356
10.3748/WJG.V19.I48.9183
P407
P577
2013-12-28T00:00:00Z